Trademark Overview
On Wednesday, September 27, 2023, a trademark application was filed for LYRONZI with the United States Patent and Trademark Office. The USPTO has given the LYRONZI trademark a serial number of 98200360. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, October 24, 2024. This trademark is owned by Rosemont Pharmaceuticals Limited. The LYRONZI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical and medical preparations for patients suffering from dysphagia and conditions requiring medication in liquid form
for the treatment of viral, bacterial, parasitic and fungal diseases and infections; oral liquid medicines for the treatment of viral,
bacterial, parasitic and fungal diseases and infections; drugs for medical purposes in the nature of medicines for the treatment of
viral, bacterial, parasitic and fungal diseases and infections; substances, drugs, medicines and medical preparations, namely,
drug delivery agents consisting of compounds in the form of oral liquid medicines, oral suspensions, dispersible and soluble
tablets, and powders to be consumed in liquid form, that facilitate the delivery of a wide range of pharmaceuticals; substances,
drugs, medicines and medical preparations, namely, drug delivery agents consisting of compounds in the form of oral liquid
medicines, oral suspensions, dispersible and soluble tablets, and powders to be consumed in liquid f...
